ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

In Brief: Survey Finds Most Localities Have Smoking Limits; Martocchio, Rickel ONS Award Speakers

April 24, 1987

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991